• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    FSD Pharma Inc. - Class B Subordinate Voting Shares (NQ: HUGE )

    0.0899 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about FSD Pharma Inc. - Class B Subordinate Voting Shares

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
    Via ACCESSWIRE
    HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024
    HUGE stock results show that FSD Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning. 
    Via InvestorPlace
    Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why FSD Pharma Stock Is Seeing Huge Gains
    FSD Pharma shares are trading higher Friday after the company provided an update on its investment in Celly Nutrition. Here's a look at what's going on: 
    Via Benzinga
    FSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation Announced
    FSD Pharma announces share consolidation, rebranding as Quantum BioPharma Ltd., and a new private placement to strengthen market position and meet Nasdaq requirements. 
    Via Benzinga
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change
    Via Investor Brand Network
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today! 
    Via InvestorPlace
    Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.
    Via Investor Brand Network
    US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
    Via Benzinga
    FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock?
    FSD Pharma stock is up on Friday as HUGe ivnestors react to an update on its investment in Celly Nutrition and a new product launch. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns! 
    Via InvestorPlace
    Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
    Via ACCESSWIRE
    Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    InvestorNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Revolutionary Rapid Detoxification Drink Spotlighted in 24/7 Market News Report
    Via Investor Brand Network
    BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Holds Annual General and Special Meeting of Shareholders, Reports on Voting Results
    Via Investor Brand Network
    BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Amends Original Material Change Report, Files Amended and Restated MCR
    Via Investor Brand Network
    BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Retains Digital Marketing Platform to Increase Market Awareness
    Via Investor Brand Network
    FSD Pharma provides Corporate Update
    Via ACCESSWIRE
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award
    Via Investor Brand Network
    FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
    Via ACCESSWIRE
    BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Notes ‘Important Step’ as Phase 1 Lucid-21-302 Trial Receives HREC Approval
    Via Investor Brand Network
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Notes ‘Important Step’ as Phase 1 Lucid-21-302 Trial Receives HREC Approval
    Via Investor Brand Network
    FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
    Via ACCESSWIRE
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Signs Option Agreement with USC to Exclusively Evaluate Novel Technology for Commercialization
    Via Investor Brand Network
    FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
    Via ACCESSWIRE
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces IRB Approval for Acute Alcohol Intoxication Study
    Via Investor Brand Network
    FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
    Via ACCESSWIRE
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.